Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Candel Therapeutics
Biotech
Candel glows with $100M RTW deal to fund cancer drug launch
As Candel gears up for a planned U.S. approval push for its prostate cancer drug, RTW has stepped in with $100 million to bankroll the launch.
James Waldron
Feb 20, 2026 4:04am
Century, Candel, MacroGenics call time on trials to save cash
Nov 13, 2025 10:15am
Biopsies illuminate potential of Candel's prostate cancer drug
May 22, 2025 6:57pm
Candel's cancer survival data light path ahead in subpopulation
Mar 27, 2025 9:48am
Candel burns bright as phase 3 cancer win sends stock up 200%
Dec 11, 2024 9:49am
Candel’s flame dims as layoffs hit 50% of the team
Nov 28, 2023 11:23am
